Impact of COVID-19 related alterations in circulating respiratory viruses on children and adult patients with recurrent wheeze and asthma
A. Peck(German Center for Lung Research), Erika von Mutius(German Center for Lung Research), Svenja Foth(Philipps University of Marburg), Ruth Grychtol(Medizinische Hochschule Hannover), Klaus F. Rabe(Christian-Albrechts-Universität zu Kiel), Nicole Maison(Center for Environmental Health), Catharina Nitsche(University Hospital Schleswig-Holstein), Bianca Schaub(LMU Klinikum), Markus Weckmann(University Hospital Schleswig-Holstein), Gesine Hansen(Medizinische Hochschule Hannover), Jimmy Omony(Helmholtz Munich), Mustafa Abdo(Heidelberg University), A-M Dittrich(Medizinische Hochschule Hannover), H. Renz(Philipps University of Marburg), Alexander Hose, MV Kopp(University Hospital of Bern), Thomas Bahmer(Christian-Albrechts-Universität zu Kiel)
Cited by 0
Related Papers
Exposure to Environmental Microorganisms and Childhood Asthma
|New England Journal of Medicine|2011|1.5k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Outcomes for COPD pharmacological trials: from lung function to biomarkers
|European Respiratory Journal|2008|856
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline
|European Respiratory Journal|2017|679
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452